The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...

Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet ...

To overcome barriers to biologic care for patients with asthma, personalized treatment is key, according to a speaker at the 16th Annual Allergy, Asthma & Immunology CME Conference.

-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized trial. JAMA 2001; 285: 2583-2593 One hundred sixty-four patients with ...

Asthma Highlights From ACAAI 2021 From ACAAI 2021, Dr Sandhya Khurana reports on advances in asthma, including novel biologic therapies, burden of corticosteroid use, and racial differences in ...

Annualized asthma exacerbation rates were compared by age group (18-49, 50-64, ≥65 years) and by biologic type (anti-immunoglobulin E [IgE] vs other biologics [anti-interleukin-5/5R/4Rs or ...

Asthma treatments include quick-relief and long-term control medications, lifestyle modifications, and avoiding triggers that can cause asthma attacks. Skip to content Health ...

While using biologics, upto 50 percent of patients have complete relief from symptoms, asthma flare ups and need of oral steroids, and these people are known to have achieved ‘Clinical Remission’.

Asthma biologics commenced before conception can be continued throughout pregnancy, including the third trimester [with the exception for tezepelumab]." Postpartum care: "9.

SAN ANTONIO — Personalized treatment strategies can help providers overcome barriers to biologic care for patients with asthma, Lukena Karkhanis, MD, said at the 16th Annual Allergy, ...

Fact checked by Jennifer Klump Dupixent (dupilumab), a drug already used to treat atopic dermatitis and asthma, became the first biologic approved for chronic obstructive pulmonary disease (COPD ...